KREBSANTIGEN-HELFERPEPTID

European patent · EP2423310 · In force

Register entry

Publication number
EP2423310
Application number
EP10767122
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 22, 2010
Published
Feb 29, 2012
Granted
Dec 17, 2014
Protection ends at the latest
Apr 21, 2030
Next annual fee due
Apr 30, 2027
IPC classes
C12N 15/09 (2006.01)
A61K 31/7088 (2006.01)
A61K 38/00 (2006.01)
A61K 48/00 (2006.01)
A61P 35/00 (2006.01)
C07K 14/82 (2006.01)
C12N 5/07 (2010.01)
C12Q 1/04 (2006.01)
C12Q 1/06 (2006.01)
G01N 33/68 (2006.01)
G01N 33/53 (2006.01)
Priority
JP 2009105286 23.04.2009
PCT application
PCT/JP2010/057149 22.04.2010
PCT publication
WO2010/123065 28.10.2010
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  4. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  5. Feb 13, 2015

    Agent entered

    Representative
    BOHEST AG, Holbeinstrasse 36-38, 4051 Basel

    Published in Swissreg on 13.02.2015

  6. Dec 17, 2014

    Granted

    Published in Swissreg on 17.12.2014

Parties

Holder

International Institute of Cancer Immunology, Inc.

13-9, Enoki-cho, Suita-shi, Osaka 564-0053, JP

Agent

BOHEST AG

Holbeinstrasse 36-38, 4051 Basel

Inventor

SUGIYAMA, Haruo

Minoo-shi Osaka 562-0036, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.